Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - MEI Pharma, Inc. | d238376d8k.htm |
| EX-4.1 - FORM OF AMENDED AND RESTATED SERIES A WARRANTS. - MEI Pharma, Inc. | d238376dex41.htm |
| EX-4.2 - FORM OF AMENDED AND RESTATED SERIES B WARRANTS. - MEI Pharma, Inc. | d238376dex42.htm |
| EX-10.3 - FORM OF SUPPLEMENTAL AGREEMENT BETWEEN THE COMPANY AND EACH INVESTOR. - MEI Pharma, Inc. | d238376dex103.htm |
| EX-99.1 - PRESS RELEASE - MEI Pharma, Inc. | d238376dex991.htm |
| EX-10.1 - SECURITIES SUBSCRIPTION AGREEMENT - MEI Pharma, Inc. | d238376dex101.htm |
Exhibit 10.2
The Board of Directors of Marshall Edwards Inc.
Marshall Edwards, Inc.
11975 El Camino Real
Suite 101
San Diego, CA 92130
Dear Board members:
On behalf of Novogen Limited (“Novogen”), Novogen unconditionally commits to make an equity investment in our subsidiary, Marshall Edwards Inc., in an amount of no less than $2,000,000 on or before June 30, 2012.
Executed on the 28th day of September 2011:
| By: | /s/ William Rueckert | |
| William Rueckert, Chairman | ||
| Novogen Limited | ||
140 Wicks Road, North Ryde NSW 2113
Tel: +6 12 9878 0088 Fax: +61 2 9878 0055